Brian Druker
Brian Druker · Science & Medicine
Oncologist who developed imatinib (Gleevec), a breakthrough targeted therapy for leukemia.
1955, St. Paul, Minnesota, United States
United States
Brian Druker is recognized among Jewish contributors to Science & Medicine — Oncologist who developed imatinib (Gleevec), a breakthrough targeted therapy for leukemia.
Born into a Jewish family of Eastern European descent, Druker is a physician-scientist at Oregon Health & Science University. Convinced that a specific molecular defect could be targeted, he championed and clinically proved imatinib (Gleevec), which blocks the abnormal BCR-ABL enzyme driving chronic myeloid leukaemia — turning a fatal disease into a manageable one and launching the era of targeted cancer therapy. He is Jewish.
Verify and go deeper with these external references.
Source: Jinfo.org — Jews in Biology
This page is published in seven languages from an English source. The translations are reviewed, but a mistake can still slip through. If you spot one on this profile — a wrong word, a lost date, a sentence that says something the English does not — please tell us.
Oncologist who developed imatinib (Gleevec), a breakthrough targeted therapy for leukemia.
Source: Jinfo.org — Jews in Biology
Similar Contributors
Ira Pastan
Emil Freireich
Henry Kaplan
James Holland
Lawrence Einhorn
